Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG

Approved

STANDARD

BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 21, 2024
Approval ID: 32e9e5dabb086ebd
Company: Glenmark Arzneimittel Gmbh
Type: Standard

Approval Details

Approval Id: 32e9e5dabb086ebd
Drug Cima Aemps Name: BILASTINA VISO FARMACÉUTICA 20 MG COMPRIMIDOS EFG
Register Number: 89128
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2024-02-21
Dosage Form: COMPRIMIDO
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

Company Information

Pharmaceutical Company Name: Glenmark Arzneimittel GmbH
Country Name: Germany
Website: http://www.glenmark.de

Active Ingredients

BILASTINA

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 21, 2024

Approval ID

32e9e5dabb086ebd

Type

Standard

Back to CIMA-AEMPS Approvals